ANALISIS LEGALISASI GANJA MEDIS UNTUK PEMENUHANHAKATAS KESEHATAN WARGA NEGARA

Achmad Arryo Nugroho, Jadmiko Anom Husodo, Sapto Hermawan

Abstract

This study aims to understand the use of medical cannabis for fulfilling citizens' health rights based on scientific research. The study examines the potential positive impacts of legalizing medical cannabis and the potential risks that might occur when a country legalizes medical cannabis. Additionally, it analyzes whether Indonesia should legalize medical cannabis based on existing scientific research. This study employs normative legal research and has a prescriptive- analytical nature, using statutory approaches, historical approaches, case approaches, comparative approaches, and conceptual approaches. This study uses primary legal materials, which are legal materials issued by official government institutions, and secondary legal materials, consisting of document publications not officially issued by state agencies. The results of the study indicate that scientific research on the potential benefits of legalizing medical cannabis is still limited. The lack of comprehensive research means that medical cannabis is not yet fully understood, and many potential benefits and risks still need to be validated. Moreover, in the context of medical cannabis, the supervision of drug distribution plays a crucial role in preventing the misuse of medical cannabis itself.Considering the known potential benefits and risks, Indonesia should not rush to legalize the use of cannabis for medical purposes. Just because many countries have started to legalize the use of cannabis for medical purposes does not mean Indonesia should force itself to legalize medical cannabis, especially since the scientific research is still in its early stages and requires further investigation

Full Text:

PDF

References

Journals:

Abouk, R., & Adams, S. (2018). Examining the relationship between medical cannabis laws and cardiovascular deaths in the US. International Journal of Drug Policy, 53, 1-7. https://doi.org/10.1016/j.drugpo.2017.11.022
Adhikari, K., Maas, A., & Trujillo-Barrera, A. (2023). Revisiting the effect of recreational marijuana on traffic fatalities. International Journal of Drug Policy, 115, 104000. https://doi.org/10.1016/j.drugpo.2023.104000
Babalonis, S., & Walsh, S. L. (2020). Therapeutic potential of opioid/cannabinoid combinations in humans: Review of the evidence. European Neuropsychopharmacology, 36, 206–216. https://doi.org/10.1016/j.euroneuro.2020.03.002
Balant, M., Gras, A., Ruz, M., Vallès, J., Vitales, D., & Garnatje, T. (2021). Traditional uses of Cannabis: An analysis of the CANNUSE database. Journal of ethnopharmacology, 279, 114362. https://doi.org/10.1016/j.jep.2021.114362
Belackova, V., Rychert, M., Wilkins, C., & Pardal, M. (2023). Cannabis Social Clubs in Contemporary Legalization Reforms: Talking Consumption Sites and Social Justice. Clinical Therapeutics, 45(6), 551–559. https://doi.org/10.1016/j.clinthera.2023.03.017
Bellam, K. G., Sabe, S. A., Chalasani, N., Feldman, N., Huang, N. R., Harwell, A., Sellke, F., & Ehsan, A. (2024). Association between marijuana use and clinical outcomes after coronary artery bypass grafting. Journal of Surgical Research, 295, 442-448. https://doi.org/10.1016/j.jss.2023.11.015
Benedetti, E., Lombardi, G., & Molinaro, S. (2023). Can drug policies modify cannabis use starting choice? Insights from criminalisation in Italy. Advances in Life Course Research, 100566. https://doi.org/10.1016/j.alcr.2023.100566
Bix, B. (2016). Radbruch’s Formula and Conceptual Analysis. Scholarship Repository. https://scholarship.law.umn.edu/faculty_articles/450/

Bonini, S. A., Premoli, M., Tambaro, S., Kumar, A., Maccarinelli, G., Memo, M., & Mastinu, A. (2018). Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history. Journal of ethnopharmacology, 227, 300–315. https://doi.org/10.1016/j.jep.2018.09.004
Bouchet, C. A., & Ingram, S. L. (2020). Cannabinoids in the descending pain modulatory circuit: Role in inflammation. Pharmacology & Therapeutics, 209, 107495. https://doi.org/10.1016/j.pharmthera.2020.107495
Braakmann, N., & Jones, S. (2014). Cannabis depenalisation, drug consumption and crime – Evidence from the 2004 cannabis declassification in the UK. Social Science & Medicine, 115, 29-37. https://doi.org/10.1016/j.socscimed.2014.06.003
Braun, I. M., Bohlke, K., Abrams, D. I., Anderson, H., Balneaves, L. G., Bar-Sela, G., Bowles, D. W., Chai, P. R., Damani, A., Gupta, A., Hallmeyer, S., Subbiah, I. M., Twelves, C., Wallace, M. S., & Roeland, E. J. (2024). Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 42(13), 1575–1593. https://doi.org/10.1200/JCO.23.02596
Buttorff, C., Wang, G. S., Wilks, A., Tung, G., Kress, A., Schwam, D., & Pacula, R. L. (2023). Impact of Recreational Cannabis Legalization on Opioid Prescribing and Opioid-Related Hospital Visits in Colorado: an Observational Study. Journal of General Internal Medicine. https://doi.org/10.1007/s11606-023-08195-3

Carrieri, V., Madio, L., & Principe, F. (2019). Light cannabis and organized crime: Evidence from (unintended) liberalization in Italy. European Economic Review, 113, 63–76. https://doi.org/10.1016/j.euroecorev.2019.01.003
Carrieri, V., Madio, L., & Principe, F. (2020). Do-It-Yourself medicine? The impact of light cannabis liberalization on prescription drugs. Journal of Health Economics, 74, 102371. https://doi.org/10.1016/j.jhealeco.2020.102371
Castle, D. J., Strauss, N., Norman, A., & Bonomo, Y. (2019). Medical Marijuana: The Australian Experience. Missouri medicine, 116(4), 270–273.
Cerdá, M., Sarvet, A. L., Wall, M., Feng, T., Keyes, K. M., Galea, S., & Hasin, D. S. (2018). Medical marijuana laws and adolescent use of marijuana and other substances: Alcohol, cigarettes, prescription drugs, and other illicit drugs. Drug and Alcohol Dependence, 183, 62-68. https://doi.org/10.1016/j.drugalcdep.2017.10.021
Červený, J., Chomynová, P., Mravčík, V., & van Ours, J. C. (2017). Cannabis decriminalization and the age of onset of cannabis use. International Journal of Drug Policy, 43, 122–129. https://doi.org/10.1016/j.drugpo.2017.02.014
Cheng, S. F., De Franco, G., & Lin, P. (2023). Marijuana liberalization and public finance: A capital market perspective on the passage of medical use laws. Journal of Accounting and Economics, 75(1), 101516. https://doi.org/10.1016/j.jacceco.2022.101516
Crocq M. A. (2020). History of cannabis and the endocannabinoid system . Dialogues in clinical neuroscience, 22(3), 223–228. https://doi.org/10.31887/DCNS.2020.22.3/mcrocq
Dave, D., Liang, Y., Pesko, M. F., Phillips, S., & Sabia, J. J. (2023). Have recreational marijuana laws undermined public health progress on adult tobacco use? Journal of Health Economics, 90, 102756. https://doi.org/10.1016/j.jhealeco.2023.102756

Dawson, D., Stjepanović, D., Lorenzetti, V., Cheung, C., Hall, W., & Leung, J. (2024). The prevalence of cannabis use disorders in people who use medicinal cannabis: A systematic review and meta-analysis. Drug and Alcohol Dependence, 257, 111263. https://doi.org/10.1016/j.drugalcdep.2024.111263
Dewey, J., & Vadlamani, S. (2023). Marijuana laws and pedestrian fatalities in the United States. IATSS Research, 47(1), 84-93. https://doi.org/10.1016/j.iatssr.2023.01.006
Dunn, T. J., Holmes, E., Yang, Y., Bentley, J. P., Kashmiri, S., & Ramachandran, S. (2023). The relationship between medical marijuana use and prescription pain reliever use among U.S. adults: A retrospective analysis utilizing the 2015–2019 national survey on drug use and health (NSDUH). Exploratory Research in Clinical and Social Pharmacy, 12, 100368. https://doi.org/10.1016/j.rcsop.2023.100368
Evaldo Favi, Leonardis, F., Tommaso Maria Manzia, Angelico, R., Yousof Alalawi, Alfieri, C., & Cacciola, R. (2021). “Salus Populi Suprema Lex”: Considerations on the Initial Response of the United Kingdom to the SARS-CoV-2 Pandemic. Frontiers in Public Health, 9. https://doi.org/10.3389/fpubh.2021.646285
Figura, M., Dariusz Koziorowski, & Jarosław Sławek. (2022). Cannabis in Parkinson’s Disease — the patient’s perspective versus clinical trials: a systematic literature review. Neurologia I Neurochirurgia Polska, 56(1), 21–27. https://doi.org/10.5603/pjnns.a2022.0004
Firth, C. L., Hajat, A., Dilley, J. A., Braun, M., & Maher, J. E. (2020). Implications of cannabis

legalization on juvenile justice outcomes and racial disparities. American Journal of Preventive Medicine, 58(4), 562-569. https://doi.org/10.1016/j.amepre.2019.11.019
Fleming, C. B., Ramirez, J. J., Rhew, I. C., Hultgren, B. A., Hanson, K. G., Larimer, M. E., Dilley, J. A., Kilmer, J. R., & Guttmannova, K. (2022). Trends in Alcohol, Cigarette, E-Cigarette, and Nonprescribed Pain Reliever Use Among Young Adults in Washington State After Legalization of Nonmedical Cannabis. Journal of Adolescent Health. https://doi.org/10.1016/j.jadohealth.2022.03.006
Flexon, J. L., Stolzenberg, L., & D'Alessio, S. J. (2019). The effect of cannabis laws on opioid use. International Journal of Drug Policy, 74, 152-159. https://doi.org/10.1016/j.drugpo.2019.09.013
García-Pérez, Á., Aonso-Diego, G., Weidberg, S., & Secades-Villa, R. (2023). Testing the cannabis gateway hypothesis in a national sample of Spanish adolescents. Addictive Behaviors, 107751. https://doi.org/10.1016/j.addbeh.2023.107751
Gerra, G., Benedetti, E., Resce, G., Potente, R., Cutilli, A., & Molinaro, S. (2020). Socioeconomic status, parental education, school connectedness and individual socio-cultural resources in vulnerability for drug use among students. International Journal of Environmental Research and Public Health, 17(4), 1306. https://doi.org/10.3390/ijerph17041306
Goedel, W. C., Macmadu, A., Shihipar, A., Moyo, P., Cerdá, M., & Marshall, B. D. (2022). Association of medical cannabis licensure with prescription opioid receipt: A population-based, individual-level retrospective cohort study. International Journal of Drug Policy, 100, 103502. https://doi.org/10.1016/j.drugpo.2021.103502

Hammond CJ, Chaney A, Hendrickson B, Sharma P. Cannabis use among U.S. adolescents in the era of marijuana legalization: a review of changing use patterns, comorbidity, and health correlates. Int Rev Psychiatry. 2020 May;32(3):221-234. doi: 10.1080/09540261.2020.1713056. Epub 2020 Feb 6. PMID: 32026735; PMCID: PMC7588219.
Hammond, C. J., Hyer, J. M., Boustead, A. E., Fristad, M. A., Steelesmith, D. L., Brock, G. N., Hasin, D. S., & Fontanella, C. A. (2024). Association between marijuana laws and suicide among 12- to 25-Year-Olds in the United States from 2000 to 2019. Journal of the American Academy of Child & Adolescent Psychiatry, 63(3), 345-354. https://doi.org/10.1016/j.jaac.2023.06.014
Han, B., Compton, W. M., Blanco, C., & Jones, C. M. (2018). Trends in and correlates of medical marijuana use among adults in the United States. Drug and Alcohol Dependence, 186, 120-129. https://doi.org/10.1016/j.drugalcdep.2018.01.022
Hasin, D. S., Borodovsky, J., Shmulewitz, D., Walsh, C., Livne, O., Struble, C. A., Aharonovich, E., Fink, D. S., & Budney, A. (2021). Use of highly-potent cannabis concentrate products: More common in U.S. states with recreational or medical cannabis laws. Drug and Alcohol Dependence, 229, 109159. https://doi.org/10.1016/j.drugalcdep.2021.109159
Hickey, J. P., Collins, A. E., Nelson, M. L., Chen, H., & Kalisch, B. E. (2024). Modulation of Oxidative Stress and Neuroinflammation by Cannabidiol (CBD): Promising Targets for the Treatment of Alzheimer’s Disease. Current Issues in Molecular Biology, 46(5), 4379–4402. https://doi.org/10.3390/cimb46050266

Hughes, B., Wiessing, L., Des Jarlais, D., & Griffiths, P. (2018). Could cannabis liberalisation lead to wider changes in drug policies and outcomes? International Journal of Drug Policy, 51, 156-159. https://doi.org/10.1016/j.drugpo.2017.10.004
Kilmer, B., & Pérez-Dávila, S. (2023). Nine insights from 10 years of legal cannabis for nonmedical purposes. Clinical Therapeutics, 45(6), 496–505. https://doi.org/10.1016/j.clinthera.2023.03.005
Kim, J. H., Martins, S. S., Shmulewitz, D., & Hasin, D. (2022). Association between fatal opioid overdose and state medical cannabis laws in US national survey data, 2000-2011. International Journal of Drug Policy, 99, 103449. https://doi.org/10.1016/j.drugpo.2021.103449
Le Foll, B. (2021). Opioid-sparing effects of cannabinoids: Myth or reality? Progress in Neuro-Psychopharmacology and Biological Psychiatry, 106, 110065. https://doi.org/10.1016/j.pnpbp.2020.110065
Leinen ZJ, Mohan R, Premadasa LS, Acharya A, Mohan M, Byrareddy SN. Therapeutic Potential of Cannabis: A Comprehensive Review of Current and Future Applications. Biomedicines. 2023; 11(10):2630. https://doi.org/10.3390/biomedicines11102630
Martínez, V., Iriondo De-Hond, A., Borrelli, F., Capasso, R., Del Castillo, M. D., & Abalo, R. (2020). Cannabidiol and Other Non-Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals?. International journal of molecular sciences, 21(9), 3067. https://doi.org/10.3390/ijms21093067
Massey, Z. B., Hammond, D., & Froeliger, B. (2024). A systematic review of cannabis health warning research. Preventive Medicine Reports, 37, 102573. https://doi.org/10.1016/j.pmedr.2023.102573
Mathur, N. K., & Ruhm, C. J. (2023). Marijuana Legalization and Opioid Deaths. Journal of Health Economics, 102728. https://doi.org/10.1016/j.jhealeco.2023.102728
McMichael, B. J., Van Horn, R. L., & Viscusi, W. K. (2020). The impact of cannabis access laws on opioid prescribing. Journal of Health Economics, 69, 102273. https://doi.org/10.1016/j.jhealeco.2019.102273
Miech, R. A., Johnston, L., O’Malley, P. M., Bachma

DOI: https://doi.org/10.20961/respublica.v9i2.89505

Refbacks

  • There are currently no refbacks.